Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INSMED IncINSM · Entity 3174 | Director · Chair and CEO | July 23, 2026 | July 24, 2026 |
| NewAmsterdam Pharma Co N.V.NAMS · Entity 1826 | Director | January 07, 2026 | January 10, 2026 |
| uniQure N.V.QURE · Entity 4162 | Director | January 27, 2017 | January 31, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INSMED Inc
Report date July 23, 2026 · Filed July 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 259,058 |
Ending reported balance
After 2026-07-23 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-07-23 · Exercise / conversion · Acquired 6,260 · Balance 265,318 F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Row 2 · 2026-07-23 · Exercise / conversion · Acquired 4,440 · Balance 269,758 F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Row 3 · 2026-07-23 · Sale · Disposed 4,828 · Balance 264,930 F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2: This is the weighted average sales price representing 4,828 shares sold at prices ranging from $105.09 to $106.02 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Row 4 · 2026-07-23 · Sale · Disposed 5,872 · Balance 259,058 F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3: This is the weighted average sales price representing 5,872 shares sold at prices ranging from $106.09 to $106.78 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $30.46 · Expires 2028-01-04 | Direct | 0 |
Reported balance
After 2026-07-23 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-07-23 · Exercise / conversion · Disposed 6,260 · Balance 0 F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.16 · Expires 2027-05-17 | Direct | 0 |
Reported balance
After 2026-07-23 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-07-23 · Exercise / conversion · Disposed 4,440 · Balance 0 F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. |
| Common StockSEC Table I · non-derivative | IndirectBy trust | 233,924 |
Reported balance
Holding disclosure · report date 2026-07-23 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 233,924 |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2: This is the weighted average sales price representing 4,828 shares sold at prices ranging from $105.09 to $106.02 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F3: This is the weighted average sales price representing 5,872 shares sold at prices ranging from $106.09 to $106.78 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F4: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
NewAmsterdam Pharma Co N.V.
Report date January 07, 2026 · Filed January 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 10,360 |
Reported balance
After 2026-01-07 transaction · row 1
1 source rowRow 1 · 2026-01-07 · Grant · Acquired 3,400 · Balance 10,360 F1: Represents restricted stock units (RSUs), each representing a contingent right to receive one ordinary share. All of the RSUs will vest on the one-year anniversary of the vesting start date, subject to the Reporting Person's continued service through such date. F2: Each RSU was granted on January 7, 2026 for no consideration. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $35.45 · Expires 2036-01-07 | Direct | 15,300 |
Reported balance
After 2026-01-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-01-07 · Grant · Acquired 15,300 · Balance 15,300 F3: All of the ordinary shares underlying the option will vest on January 2, 2027, the one-year anniversary of the vesting start date, subject to the Reporting Person's continued service through such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units (RSUs), each representing a contingent right to receive one ordinary share. All of the RSUs will vest on the one-year anniversary of the vesting start date, subject to the Reporting Person's continued service through such date.
F2: Each RSU was granted on January 7, 2026 for no consideration.
F3: All of the ordinary shares underlying the option will vest on January 2, 2027, the one-year anniversary of the vesting start date, subject to the Reporting Person's continued service through such date.
uniQure N.V.
Report date January 27, 2017 · Filed January 31, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.37 · Expires 2027-01-27 | Direct | 11,000 |
Reported balance
After 2017-01-27 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-01-27 · Grant · Acquired 11,000 · Balance 11,000 F1: The Stock Option vests 100% on January 27, 2018. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 16,000 |
Reported balance
After 2017-01-27 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-01-27 · Grant · Acquired 11,000 · Balance 16,000 F2: The Restricted Stock Unit vests 100% on January 27, 2018. F3: Expiration date is not applicable as the vested Restricted Stock Units shall be settled on the first business day following the date that such Restricted Stock Units vests. |
Filing footnotes · ownership attribution and instrument terms
F1: The Stock Option vests 100% on January 27, 2018.
F2: The Restricted Stock Unit vests 100% on January 27, 2018.
F3: Expiration date is not applicable as the vested Restricted Stock Units shall be settled on the first business day following the date that such Restricted Stock Units vests.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 30, 2020 Filed Jan 6, 2021 22:11 UTC | INSMED Inc INSM · Entity 3174 | GiftStock Option (right to buy) · Derivative | 57,000 | $0.00 Strike: $14.24 | $0.00 |
DisclosureSEC source: 0001104659-21-001601 · tm211774-1_4seq1.xml · derivative · entry 24 Lewis William · CIK 0001402051 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 57,000 Underlying: Common Stock · 57,000 shares Expires 2023-10-31 F4 · kind: The reported transactions involve a gift of securities by the reporting person to his spouse. F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| December 30, 2020 Filed Jan 6, 2021 22:11 UTC | INSMED Inc INSM · Entity 3174 | GiftStock Option (right to buy) · Derivative | 57,000 | $0.00 Strike: $14.24 | $0.00 |
DisclosureSEC source: 0001104659-21-001601 · tm211774-1_4seq1.xml · derivative · entry 23 Lewis William · CIK 0001402051 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,456 Underlying: Common Stock · 57,000 shares Expires 2023-10-31 F4 · kind: The reported transactions involve a gift of securities by the reporting person to his spouse. F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| December 30, 2020 Filed Jan 6, 2021 22:11 UTC | INSMED Inc INSM · Entity 3174 | GiftStock Option (right to buy) · Derivative | 67,257 | $0.00 Strike: $12.44 | $0.00 |
DisclosureSEC source: 0001104659-21-001601 · tm211774-1_4seq1.xml · derivative · entry 20 Lewis William · CIK 0001402051 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 67,257 Underlying: Common Stock · 67,257 shares Expires 2023-05-23 F4 · kind: The reported transactions involve a gift of securities by the reporting person to his spouse. F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| December 30, 2020 Filed Jan 6, 2021 22:11 UTC | INSMED Inc INSM · Entity 3174 | GiftStock Option (right to buy) · Derivative | 67,257 | $0.00 Strike: $12.44 | $0.00 |
DisclosureSEC source: 0001104659-21-001601 · tm211774-1_4seq1.xml · derivative · entry 19 Lewis William · CIK 0001402051 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 67,257 shares Expires 2023-05-23 F4 · kind: The reported transactions involve a gift of securities by the reporting person to his spouse. F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| December 30, 2020 Filed Jan 6, 2021 22:11 UTC | INSMED Inc INSM · Entity 3174 | GiftStock Option (right to buy) · Derivative | 83,333 | $0.00 Strike: $12.44 | $0.00 |
DisclosureSEC source: 0001104659-21-001601 · tm211774-1_4seq1.xml · derivative · entry 16 Lewis William · CIK 0001402051 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 83,333 Underlying: Common Stock · 83,333 shares Expires 2023-05-23 F4 · kind: The reported transactions involve a gift of securities by the reporting person to his spouse. F5 · derivative.exercise_date: These options became exercisable upon the achievement of certain performance criteria. Read SEC document |
| December 30, 2020 Filed Jan 6, 2021 22:11 UTC | INSMED Inc INSM · Entity 3174 | GiftStock Option (right to buy) · Derivative | 83,333 | $0.00 Strike: $12.44 | $0.00 |
DisclosureSEC source: 0001104659-21-001601 · tm211774-1_4seq1.xml · derivative · entry 15 Lewis William · CIK 0001402051 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 83,333 shares Expires 2023-05-23 F4 · kind: The reported transactions involve a gift of securities by the reporting person to his spouse. F5 · derivative.exercise_date: These options became exercisable upon the achievement of certain performance criteria. Read SEC document |
| December 30, 2020 Filed Jan 6, 2021 22:11 UTC | INSMED Inc INSM · Entity 3174 | GiftStock Option (right to buy) · Derivative | 83,334 | $0.00 Strike: $12.44 | $0.00 |
DisclosureSEC source: 0001104659-21-001601 · tm211774-1_4seq1.xml · derivative · entry 12 Lewis William · CIK 0001402051 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 83,334 Underlying: Common Stock · 83,334 shares Expires 2023-05-23 F4 · kind: The reported transactions involve a gift of securities by the reporting person to his spouse. F5 · derivative.exercise_date: These options became exercisable upon the achievement of certain performance criteria. Read SEC document |
| December 30, 2020 Filed Jan 6, 2021 22:11 UTC | INSMED Inc INSM · Entity 3174 | GiftStock Option (right to buy) · Derivative | 83,334 | $0.00 Strike: $12.44 | $0.00 |
DisclosureSEC source: 0001104659-21-001601 · tm211774-1_4seq1.xml · derivative · entry 11 Lewis William · CIK 0001402051 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 83,334 shares Expires 2023-05-23 F4 · kind: The reported transactions involve a gift of securities by the reporting person to his spouse. F5 · derivative.exercise_date: These options became exercisable upon the achievement of certain performance criteria. Read SEC document |
| December 30, 2020 Filed Jan 6, 2021 22:11 UTC | INSMED Inc INSM · Entity 3174 | GiftStock Option (right to buy) · Derivative | 175,530 | $0.00 Strike: $13.67 | $0.00 |
DisclosureSEC source: 0001104659-21-001601 · tm211774-1_4seq1.xml · derivative · entry 10 Lewis William · CIK 0001402051 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020 Disclosed balance after: 175,530 Underlying: Common Stock · 175,530 shares Expires 2027-01-05 F1 · kind: The reported transactions involve the reporting person's transfer of options to a family trust, ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020. Members of the reporting person's immediate family are the sole beneficiaries of the trust. F3 · derivative.exercise_date: The options were granted on January 9, 2017 and become exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| December 30, 2020 Filed Jan 6, 2021 22:11 UTC | INSMED Inc INSM · Entity 3174 | GiftStock Option (right to buy) · Derivative | 175,530 | $0.00 Strike: $13.67 | $0.00 |
DisclosureSEC source: 0001104659-21-001601 · tm211774-1_4seq1.xml · derivative · entry 9 Lewis William · CIK 0001402051 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 175,530 shares Expires 2027-01-05 F1 · kind: The reported transactions involve the reporting person's transfer of options to a family trust, ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020. Members of the reporting person's immediate family are the sole beneficiaries of the trust. F3 · derivative.exercise_date: The options were granted on January 9, 2017 and become exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| December 30, 2020 Filed Jan 6, 2021 22:11 UTC | INSMED Inc INSM · Entity 3174 | GiftStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $12.58 | $0.00 |
DisclosureSEC source: 0001104659-21-001601 · tm211774-1_4seq1.xml · derivative · entry 8 Lewis William · CIK 0001402051 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020 Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2024-06-02 F1 · kind: The reported transactions involve the reporting person's transfer of options to a family trust, ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020. Members of the reporting person's immediate family are the sole beneficiaries of the trust. F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| December 30, 2020 Filed Jan 6, 2021 22:11 UTC | INSMED Inc INSM · Entity 3174 | GiftStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $12.58 | $0.00 |
DisclosureSEC source: 0001104659-21-001601 · tm211774-1_4seq1.xml · derivative · entry 7 Lewis William · CIK 0001402051 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2024-06-02 F1 · kind: The reported transactions involve the reporting person's transfer of options to a family trust, ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020. Members of the reporting person's immediate family are the sole beneficiaries of the trust. F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| December 30, 2020 Filed Jan 6, 2021 22:11 UTC | INSMED Inc INSM · Entity 3174 | GiftStock Option (right to buy) · Derivative | 55,500 | $0.00 Strike: $14.24 | $0.00 |
DisclosureSEC source: 0001104659-21-001601 · tm211774-1_4seq1.xml · derivative · entry 6 Lewis William · CIK 0001402051 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020 Disclosed balance after: 55,500 Underlying: Common Stock · 55,500 shares Expires 2023-10-31 F1 · kind: The reported transactions involve the reporting person's transfer of options to a family trust, ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020. Members of the reporting person's immediate family are the sole beneficiaries of the trust. F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| December 30, 2020 Filed Jan 6, 2021 22:11 UTC | INSMED Inc INSM · Entity 3174 | GiftStock Option (right to buy) · Derivative | 55,500 | $0.00 Strike: $14.24 | $0.00 |
DisclosureSEC source: 0001104659-21-001601 · tm211774-1_4seq1.xml · derivative · entry 5 Lewis William · CIK 0001402051 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,456 Underlying: Common Stock · 55,500 shares Expires 2023-10-31 F1 · kind: The reported transactions involve the reporting person's transfer of options to a family trust, ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020. Members of the reporting person's immediate family are the sole beneficiaries of the trust. F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| December 30, 2020 Filed Jan 6, 2021 22:11 UTC | INSMED Inc INSM · Entity 3174 | GiftStock Option (right to buy) · Derivative | 186,170 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001104659-21-001601 · tm211774-1_4seq1.xml · derivative · entry 4 Lewis William · CIK 0001402051 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020 Disclosed balance after: 186,170 Underlying: Common Stock · 186,170 shares Expires 2022-09-28 F1 · kind: The reported transactions involve the reporting person's transfer of options to a family trust, ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020. Members of the reporting person's immediate family are the sole beneficiaries of the trust. F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| December 30, 2020 Filed Jan 6, 2021 22:11 UTC | INSMED Inc INSM · Entity 3174 | GiftStock Option (right to buy) · Derivative | 186,170 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001104659-21-001601 · tm211774-1_4seq1.xml · derivative · entry 3 Lewis William · CIK 0001402051 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 186,170 shares Expires 2022-09-28 F1 · kind: The reported transactions involve the reporting person's transfer of options to a family trust, ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020. Members of the reporting person's immediate family are the sole beneficiaries of the trust. F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| December 30, 2020 Filed Jan 6, 2021 22:11 UTC | INSMED Inc INSM · Entity 3174 | GiftStock Option (right to buy) · Derivative | 30,630 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001104659-21-001601 · tm211774-1_4seq1.xml · derivative · entry 2 Lewis William · CIK 0001402051 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020 Disclosed balance after: 30,630 Underlying: Common Stock · 30,630 shares Expires 2022-09-10 F1 · kind: The reported transactions involve the reporting person's transfer of options to a family trust, ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020. Members of the reporting person's immediate family are the sole beneficiaries of the trust. F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| December 30, 2020 Filed Jan 6, 2021 22:11 UTC | INSMED Inc INSM · Entity 3174 | GiftStock Option (right to buy) · Derivative | 30,630 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001104659-21-001601 · tm211774-1_4seq1.xml · derivative · entry 1 Lewis William · CIK 0001402051 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 30,360 shares Expires 2022-09-10 F1 · kind: The reported transactions involve the reporting person's transfer of options to a family trust, ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020. Members of the reporting person's immediate family are the sole beneficiaries of the trust. F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| December 22, 2020 Filed Dec 23, 2020 21:15 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001104659-20-139098 · tm2039285d1_4.xml · derivative · entry 4 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,630 Underlying: Common Stock · 50,000 shares Expires 2022-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| December 22, 2020 Filed Dec 23, 2020 21:15 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 11,633 | $36.98 | $430,188.34 |
DisclosureSEC source: 0001104659-20-139098 · tm2039285d1_4.xml · nonDerivative · entry 3 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,787 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 11,633 shares sold at prices ranging from $36.83 to $37.46 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| December 22, 2020 Filed Dec 23, 2020 21:15 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 38,367 | $36.45 | $1,398,477.15 |
DisclosureSEC source: 0001104659-20-139098 · tm2039285d1_4.xml · nonDerivative · entry 2 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,420 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 38,367 shares sold at prices ranging from $35.83 to $36.82 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| December 22, 2020 Filed Dec 23, 2020 21:15 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 50,000 | $3.40 | $170,000.00 |
DisclosureSEC source: 0001104659-20-139098 · tm2039285d1_4.xml · nonDerivative · entry 1 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,787 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| November 06, 2020 Filed Nov 6, 2020 23:10 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 4,880 | $0.00 Strike: $20.49 | $0.00 |
DisclosureSEC source: 0001104659-20-122622 · a4.xml · derivative · entry 37 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,880 shares Expires 2024-01-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| November 06, 2020 Filed Nov 6, 2020 23:10 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 14,044 | $0.00 Strike: $14.24 | $0.00 |
DisclosureSEC source: 0001104659-20-122622 · a4.xml · derivative · entry 36 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,044 shares Expires 2023-10-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| November 06, 2020 Filed Nov 6, 2020 23:10 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 16,076 | $0.00 Strike: $12.44 | $0.00 |
DisclosureSEC source: 0001104659-20-122622 · a4.xml · derivative · entry 35 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,076 shares Expires 2023-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| November 06, 2020 Filed Nov 6, 2020 23:10 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 4,880 | $20.49 | $99,991.20 |
DisclosureSEC source: 0001104659-20-122622 · a4.xml · nonDerivative · entry 24 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,787 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2020 Filed Nov 6, 2020 23:10 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 14,044 | $14.24 | $199,986.56 |
DisclosureSEC source: 0001104659-20-122622 · a4.xml · nonDerivative · entry 23 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,907 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2020 Filed Nov 6, 2020 23:10 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 16,076 | $12.44 | $199,985.44 |
DisclosureSEC source: 0001104659-20-122622 · a4.xml · nonDerivative · entry 22 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,863 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 23:10 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 17,349 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001104659-20-122622 · a4.xml · derivative · entry 34 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,630 Underlying: Common Stock · 17,349 shares Expires 2022-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 23:10 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 4,123 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001104659-20-122622 · a4.xml · derivative · entry 33 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,979 Underlying: Common Stock · 4,123 shares Expires 2022-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 23:10 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 17,802 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001104659-20-122622 · a4.xml · derivative · entry 32 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,102 Underlying: Common Stock · 17,802 shares Expires 2022-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 23:10 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 24,221 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001104659-20-122622 · a4.xml · derivative · entry 31 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,904 Underlying: Common Stock · 24,221 shares Expires 2022-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 23:10 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 26,169 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001104659-20-122622 · a4.xml · derivative · entry 30 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,125 Underlying: Common Stock · 26,169 shares Expires 2022-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 23:10 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 49,736 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001104659-20-122622 · a4.xml · derivative · entry 29 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,294 Underlying: Common Stock · 49,736 shares Expires 2022-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 23:10 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 21,748 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001104659-20-122622 · a4.xml · derivative · entry 28 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 370,030 Underlying: Common Stock · 21,748 shares Expires 2022-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 23:10 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 13,534 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001104659-20-122622 · a4.xml · derivative · entry 27 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 391,778 Underlying: Common Stock · 13,534 shares Expires 2022-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 23:10 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 18,976 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001104659-20-122622 · a4.xml · derivative · entry 26 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 405,312 Underlying: Common Stock · 18,976 shares Expires 2022-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 23:10 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 6,342 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001104659-20-122622 · a4.xml · derivative · entry 25 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424,288 Underlying: Common Stock · 6,342 shares Expires 2022-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 23:10 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 17,349 | $33.59 | $582,752.91 |
DisclosureSEC source: 0001104659-20-122622 · a4.xml · nonDerivative · entry 21 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,787 F11 · price: This is the weighted average sales price representing 17,349 shares sold at prices ranging from $32.96 to $33.69 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 23:10 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 17,349 | $3.40 | $58,986.60 |
DisclosureSEC source: 0001104659-20-122622 · a4.xml · nonDerivative · entry 20 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 23:10 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 4,123 | $35.19 | $145,088.37 |
DisclosureSEC source: 0001104659-20-122622 · a4.xml · nonDerivative · entry 19 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,787 F10 · price: This is the weighted average sales price representing 4,123 shares sold at prices ranging from $35.14 to $35.22 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 23:10 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 4,123 | $3.40 | $14,018.20 |
DisclosureSEC source: 0001104659-20-122622 · a4.xml · nonDerivative · entry 18 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,910 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 23:10 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 17,802 | $34.88 | $620,933.76 |
DisclosureSEC source: 0001104659-20-122622 · a4.xml · nonDerivative · entry 17 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,787 F9 · price: This is the weighted average sales price representing 17,802 shares sold at prices ranging from $34.73 to $35.11 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 23:10 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 17,802 | $3.40 | $60,526.80 |
DisclosureSEC source: 0001104659-20-122622 · a4.xml · nonDerivative · entry 16 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,589 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 23:10 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 24,221 | $34.05 | $824,725.05 |
DisclosureSEC source: 0001104659-20-122622 · a4.xml · nonDerivative · entry 15 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,787 F8 · price: This is the weighted average sales price representing 24,221 shares sold at prices ranging from $33.94 to $34.25 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 23:10 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 24,221 | $3.40 | $82,351.40 |
DisclosureSEC source: 0001104659-20-122622 · a4.xml · nonDerivative · entry 14 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,008 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 23:10 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 26,169 | $34.62 | $905,970.78 |
DisclosureSEC source: 0001104659-20-122622 · a4.xml · nonDerivative · entry 13 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,787 F7 · price: This is the weighted average sales price representing 26,169 shares sold at prices ranging from $34.50 to $34.72 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 23:10 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 26,169 | $3.40 | $88,974.60 |
DisclosureSEC source: 0001104659-20-122622 · a4.xml · nonDerivative · entry 12 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,956 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 23:10 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 49,736 | $33.78 | $1,680,082.08 |
DisclosureSEC source: 0001104659-20-122622 · a4.xml · nonDerivative · entry 11 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,787 F6 · price: This is the weighted average sales price representing 49,736 shares sold at prices ranging from $33.70 to $33.93 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 23:10 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 49,736 | $3.40 | $169,102.40 |
DisclosureSEC source: 0001104659-20-122622 · a4.xml · nonDerivative · entry 10 Lewis William · CIK 0001402051 · Director · Chair&Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,523 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.